Stage IIIA Gastric Cancer (DBCOND0030407)

Identifiers

Synonyms
Gastric Cancer Stage IIIA

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT06342427
Stomach Cancer Exosome-based DetectionNo drug interventionsNot AvailableNot Availablecompleted
NCT02511821
Electronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in Patients With Gastrointestinal Cancer Undergoing SurgeryNo drug interventionsdevice_feasibilityNot Availablecompleted
NCT00991952
Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach or Gastroesophageal Junction Cancer That Cannot Be Removed By Surgerytreatment2completed
NCT05856500
A Study of Creatine Combined With Curcumin in the Intervention of Early Cachexia in Upper Gastrointestinal TumorsNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT00064259
A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancertreatment1 / 2terminated
NCT02366819
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancertreatment4recruiting
NCT01212822
Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancertreatment2completed
NCT01846520
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung CancersNo drug interventionssupportive_careNot Availablecompleted
NCT00982592
Combination Chemotherapy With or Without Vismodegib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancertreatment2completed
NCT02344810
C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancertreatment1 / 2withdrawn
NCT03154190
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With CancerNo drug interventionshealth_services_researchNot Availableunknown_status
NCT02333188
Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancertreatment1completed
NCT01939275
64Cu DOTA-Trastuzumab PET/CT in Studying Patients With Gastric CancerNo drug interventionsdiagnosticNot Availableactive_not_recruiting
NCT01643499
Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignanciestreatment1completed
NCT00084617
Phase II Study of Oxaliplatin, Irinotecan, and Capecitabine in Advanced Gastric/Gastroesophageal Junction Carcinomatreatment2completed
NCT02567396
Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunctiontreatment1withdrawn
NCT00084604
Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinomatreatment2completed